V024-5267 Screening compound: 4-[({4-[cyclohexyl(methyl)amino]-6-ethylpyrimidin-2-yl}sulfanyl)methyl]-N-[(oxolan-2-yl)methyl]benzamide

V024-5267 Screening compound: 4-[({4-[cyclohexyl(methyl)amino]-6-ethylpyrimidin-2-yl}sulfanyl)methyl]-N-[(oxolan-2-yl)methyl]benzamide
V024-5267 Screening compound: 4-[({4-[cyclohexyl(methyl)amino]-6-ethylpyrimidin-2-yl}sulfanyl)methyl]-N-[(oxolan-2-yl)methyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-5267
4-[({4-[cyclohexyl(methyl)amino]-6-ethylpyrimidin-2-yl}sulfanyl)methyl]-N-[(oxolan-2-yl)methyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-5267

Molecular Formula

C26H36N4O2S (C26 H36 N4 O2 S)

Compound Name

4-[({4-[cyclohexyl(methyl)amino]-6-ethylpyrimidin-2-yl}sulfanyl)methyl]-N-[(oxolan-2-yl)methyl]benzamide

IUPAC name

4-[({4-[cyclohexyl(methyl)amino]-6-ethylpyrimidin-2-yl}sulfanyl)methyl]-N-[(oxolan-2-yl)methyl]benzamide

SMILES

CCc1nc(SCc(cc2)ccc2C(NCC2OCCC2)=O)nc(N(C)C2CCCCC2)c1

InChI

InChI=1S/C26H36N4O2S/c1-3-21-16-24(30(2)22-8-5-4-6-9-22)29-26(28-21)33-18-19-11-13-20(14-12-19)25(31)27-17-23-10-7-15-32-23/h11-14,16,22-23H,3-10,15,17-18H2,1-2H3,(H,27,31)/t23-/m1/s1

InChI Key

LHNUFJACQHCBKZ-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD19817867

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

468.66

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.609

Distribution Coefficient, logD

4.609

Water Solubility, LogSw

-4.31

Polar Surface Area

52.293

Acid Dissociation Constant (pKa)

12.79

Base Dissociation Constant (pKb)

4.34

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

57.70

V024-5267 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V024-5267 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-5267?
Check Price and Availability of V024-5267, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-5267 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-5267
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-5267
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-5267 available by request